Lung Abscess

The abscess wall: pus walled off by scar
The abscess wall: pus walled off by scar

A lung abscess is a localized collection of pus within an area of destroyed lung parenchyma, forming a thick-walled, necrotic cavity. The condition is life-threatening if untreated yet highly curable with the right antibiotic selection and adequate drainage. Most cases arise from aspiration of oropharyngeal bacteria in people with altered consciousness or poor dentition, and anaerobes dominate the microbiology. Understanding the distinction between primary and secondary lung abscess — and identifying the causative organism — is essential for directing treatment and predicting outcome.

Table of Contents

  1. Primary vs. Secondary Lung Abscess
  2. Risk Factors for Aspiration
  3. Microbiology
  4. Pathophysiology and Location
  5. Symptoms and Clinical Presentation
  6. Diagnosis: Imaging and Laboratory
  7. Antibiotic Treatment
  8. Drainage and Surgical Intervention
  9. Outcomes and Complications
  10. Key Research Papers
  11. Featured Videos

Primary vs. Secondary Lung Abscess

The first and most clinically important distinction is whether the abscess arises in otherwise normal lung (primary) or as a complication of an underlying structural or systemic problem (secondary). This classification shapes the diagnostic workup, the expected microbiology, and the likelihood of cure with antibiotics alone.

Primary Lung Abscess

Primary lung abscess accounts for approximately 65% of cases and is almost always caused by aspiration of infected oropharyngeal material into the lung in a susceptible host. Because the host's normal lung architecture was intact before the event, the abscess is the only lesion and the surrounding lung is otherwise healthy. Response to antibiotics alone is excellent — approximately 85–90% of primary abscesses resolve without invasive intervention.

Secondary Lung Abscess

Secondary lung abscess occurs as a consequence of an identifiable underlying cause that sets the stage for infection. The major categories include:

Risk Factors for Aspiration

Because the majority of lung abscesses arise from aspiration, recognizing the circumstances that impair the normal oropharyngeal defense against aspiration is foundational. The aspiration events that lead to lung abscess are typically silent — small-volume microaspirations of oropharyngeal secretions during sleep, not dramatic witnessed large-volume events. It is the combination of bacterial load in the oropharynx (primarily from dental disease), impaired cough reflex, and impaired consciousness that allows organisms to reach the distal airways in sufficient numbers to establish infection.

Major Aspiration Risk Factors

Microbiology

The bacteriology of lung abscess is fundamentally driven by the mechanism of formation, and the distinction between aspiration-primary and non-aspiration causes is decisive.

Anaerobes: The Dominant Organisms in Aspiration Abscess

In Western series, mixed anaerobic bacteria from the oropharyngeal flora are the predominant cause of primary (aspiration-related) lung abscesses. The oropharynx harbors enormous concentrations of anaerobes — up to 108 organisms per mL of saliva — so even small aspirations deliver large numbers. The major culprits include:

Cultures of expectorated sputum are generally unreliable for anaerobes because the specimen is invariably contaminated by oropharyngeal flora containing the same organisms. Reliable anaerobic cultures require bronchoscopic protected specimen brush sampling, transtracheal aspiration, or percutaneous needle aspiration — procedures not routinely required when the clinical picture is classic for aspiration abscess. In practice, most primary anaerobic abscesses are treated empirically based on clinical diagnosis.

Aerobic and Facultative Organisms

The Germs Differ by Country

The germs behind lung abscess are not the same everywhere. In a Taiwanese series of 90 adults with community-acquired lung abscess treated in 1995–2003, Klebsiella pneumoniae caused 21% of cases; it was linked to diabetes (odds ratio 4.3), and people with it more often had germs in the bloodstream, a slower fall in fever and several cavities on X-ray than people with an anaerobic abscess. The same series reported that a growing share of anaerobes and Streptococcus milleri group germs were no longer susceptible to clindamycin and penicillin. In a Japanese series of 205 adults, among the 122 with a germ identified, Streptococcus species were the most common (59.8%), ahead of anaerobes (26.2%), Gemella species (9.8%) and K. pneumoniae (8.2%).

Pathophysiology and Location

The anatomical location of the abscess provides an important diagnostic clue and reflects the mechanism of aspiration. When aspiration occurs in a recumbent patient, aspirated material flows by gravity into the most dependent lung segments. Understanding which segments are dependent in which body positions determines the classic locations of aspiration-related lung abscess.

Dependent Segment Distribution

Aspiration of infected material initiates a sequence: pneumonitis → consolidation → central necrosis → cavitation as the destructive enzymes of bacteria and neutrophils break down lung parenchyma. The thick fibrous wall that forms around the necrotic core is the body's attempt to contain the infection. When the necrotic cavity communicates with an airway, an air-fluid level becomes visible on imaging — this is the hallmark radiographic finding. The contents are then partially expectorated, producing the characteristic foul-smelling, putrid sputum that is almost pathognomonic of anaerobic lung abscess.

Distinguishing Abscess from Empyema

On imaging, a lung abscess and an empyema (pus in the pleural space) can appear similar — both show fluid-containing cavities with air-fluid levels. The distinction is critical because empyema requires pleural drainage while abscess is managed primarily with antibiotics. Key distinguishing features on computed tomography (CT) chest:

Symptoms and Clinical Presentation

The clinical presentation of lung abscess has a characteristic tempo — insidious, subacute onset over days to weeks — that distinguishes it from acute bacterial pneumonia, which typically presents more abruptly. This subacute course reflects the slow progression from pneumonitis to cavitation and the relative inefficiency of anaerobes as acute pathogens (compared with virulent organisms like Streptococcus pneumoniae).

Common Symptoms

Physical Examination

Physical examination findings are variable but often include fever, signs of consolidation (dullness, bronchial breathing) over the affected area, and — in chronic or large abscesses — amphoric (hollow, jug-like) breath sounds over the cavity. Signs of poor dentition, alcohol-related liver disease, or neurological disorders that impair swallowing are important contextual clues. Clubbing of the fingers may be seen in prolonged cases (more than 6–8 weeks duration) reflecting chronic suppurative lung disease.

Diagnosis: Imaging and Laboratory

The diagnosis of lung abscess is primarily radiological and requires identifying a thick-walled cavitary lesion with or without an air-fluid level within it. Laboratory findings confirm infection and guide antibiotic selection.

Chest X-ray

Chest X-ray is the initial imaging modality and typically shows a thick-walled cavitary lesion with a central air-fluid level — the presence of both air and fluid within the cavity means the necrotic center has communicated with an airway and some contents have been expectorated. The surrounding parenchyma often shows consolidation. The abscess may be single or, in hematogenous cases, multiple. Early in the disease course (before cavitation occurs), the X-ray may show only dense consolidation indistinguishable from pneumonia.

Computed Tomography Chest

Computed tomography chest with contrast is the definitive imaging modality. Advantages over plain X-ray include:

Bronchoscopy

Bronchoscopy is indicated when post-obstructive abscess is suspected (older patients, smokers, absence of typical aspiration risk factors), when the abscess does not respond to antibiotics as expected, or when a tissue diagnosis is required. Bronchoscopy allows direct visualization of the bronchial tree, biopsy of endobronchial lesions, and protected specimen brush sampling for reliable microbiological culture (avoiding oropharyngeal contamination). Reviews describe doing bronchoscopy after at least some antibiotic treatment, to reduce the risk of flooding the airway with large volumes of purulent material during the procedure.

Sputum and Blood Cultures

Expectorated sputum cultures have limited value for anaerobes due to oropharyngeal contamination but remain useful for detecting aerobes and facultative organisms. Three sets of blood cultures are commonly drawn in a febrile patient with lung abscess — positive blood cultures establish bacteremia, implicate the causative organism, and raise concern for a hematogenous source (endocarditis, septic thrombophlebitis). Blood cultures are particularly important in suspected S. aureus or Klebsiella abscess.

Laboratory Findings

Laboratory findings reflect a subacute infectious and inflammatory process:

Antibiotic Treatment

Antibiotic therapy is the cornerstone of lung abscess management. The choice of antibiotic depends on the mechanism (aspiration vs. non-aspiration) and the likely pathogens. Duration of therapy is prolonged compared to community-acquired pneumonia — typically 3–6 weeks — reflecting the need to penetrate the thick abscess wall and eradicate organisms within the necrotic cavity, where local oxygen tension is low (favoring anaerobes) and blood supply is impaired.

Clindamycin: The Preferred Agent for Anaerobic Aspiration Abscess

Clindamycin has excellent activity against oropharyngeal anaerobes and achieves adequate concentrations in lung tissue. It is the preferred antibiotic for aspiration-related lung abscess based on a landmark randomized trial.

The Levison et al. trial (1983) compared clindamycin with penicillin in a randomized study of community-acquired putrid (foul-smelling) lung abscess. People given clindamycin had fever for a shorter time (mean 4.4 vs. 7.6 days) and fewer days of foul sputum (4.2 vs. 8.0 days). Within 10 days, the infection spread within the lung or to the pleura in 4 of 20 people on penicillin and in none of 19 on clindamycin. Of the people who could be followed to the end of the study, all 13 on clindamycin were cured, against 8 of 15 on penicillin. The authors concluded that penicillin "may not be optimal therapy" for anaerobic lung abscess. The reason for penicillin's inferiority is that many oropharyngeal anaerobes, including Bacteroides species, produce beta-lactamases that inactivate penicillin. Clindamycin is not a beta-lactam and is unaffected by this resistance mechanism. This trial is the main basis for clindamycin's place in treating primary aspiration lung abscess. It was small (39 people), and a 2024 review notes that high-quality evidence and guidelines for treating lung abscess are still lacking.

Clindamycin Dosing and Step-Down

Typical regimen: clindamycin 600 mg intravenous every 8 hours until clinically improved (usually 5–7 days), then step down to oral clindamycin 300–450 mg every 6 hours to complete a total course of 3–6 weeks. The total duration depends on clinical and radiological response — treatment is usually continued until the cavity has resolved or is small and stable on imaging and the patient is clinically well.

Alternative: Amoxicillin-Clavulanate

Amoxicillin-clavulanate (oral: 875/125 mg twice daily; intravenous: ampicillin-sulbactam) is a reasonable alternative to clindamycin for aspiration abscess. The clavulanate component inhibits beta-lactamases produced by Bacteroides and other anaerobes, restoring activity against these organisms. It is particularly useful in patients who cannot tolerate clindamycin (diarrhea, rash, or concern for C. difficile colitis — a well-recognized risk with clindamycin use).

Special Microbiological Situations

Monitoring Response

Response to antibiotics in lung abscess is slower than in uncomplicated pneumonia. Fever usually resolves over 3–10 days, and the cavity shrinks gradually on imaging over weeks. When there is no improvement after 7–10 days of appropriate antibiotics, reviews describe reassessing four points: whether the organism is covered, whether an obstructing lesion is present, whether drainage is needed, and whether the antibiotics are actually being taken and absorbed.

Drainage and Surgical Intervention

Most primary lung abscesses drain spontaneously through the bronchial tree as the cavity communicates with an airway and contents are expectorated. The approximately 75–90% medical cure rate for primary aspiration abscess means that many patients never require any invasive drainage procedure. The challenge is identifying the 10–25% who will fail medical therapy and need intervention — ideally before they deteriorate significantly.

Indications for Drainage

Percutaneous Computed Tomography-Guided Drainage

Image-guided percutaneous drainage (computed tomography or ultrasound) has emerged as the preferred invasive approach for abscesses that fail medical management and are accessible without traversing major airways or vessels. A drainage catheter is placed under computed tomography guidance directly into the abscess cavity through the chest wall. Success rates are high (80–90% in selected series), and the procedure avoids the risks of general anesthesia and surgery. The main concern is the risk of bronchopleural fistula if the catheter traverses normal lung parenchyma — operators reduce this risk by choosing a route directly through consolidated lung rather than aerated lung.

A 2022 pooled analysis of 26 studies (194 patients) found that a drain placed through the chest wall under imaging guidance cleared the abscess in 86.5%; serious complications occurred in 8.1%, and 1.5% died of an abscess that could not be controlled. A catheter passing through healthy lung was the only significant risk factor for serious complications (odds ratio 27.69), and abscesses caused by cancer were less likely to clear. An earlier 2002 review of 25 years of reports put procedure complications at 9.7% (blocked catheter, chest pain, collapsed lung and bleeding into the chest) and deaths from the abscess at 4.8%.

Bronchoscopic Drainage

In select cases, bronchoscopic drainage using a catheter advanced through the bronchus directly into the abscess cavity can provide therapeutic benefit. This approach is most applicable when the abscess communicates with an airway (visible air-fluid level) and the patient cannot tolerate percutaneous drainage.

Surgical Resection

Surgery — typically pneumonectomy or lobectomy via video-assisted thoracoscopic surgery (VATS, keyhole chest surgery) or open thoracotomy — is reserved for the minority of cases that fail all other measures. Indications include:

Surgery carries significant morbidity in this patient population (often debilitated, with poor nutritional status and cardiopulmonary reserve), so it is reserved for clear indications after medical management has been maximized.

Outcomes and Complications

The prognosis of lung abscess depends primarily on the mechanism, the causative organism, the patient's immune status, and whether an underlying obstructing lesion is present.

Primary Aspiration Abscess

With clindamycin or amoxicillin-clavulanate, 75–90% of primary aspiration abscesses resolve completely. Clinical improvement (defervescence, reduced sputum) typically precedes radiological improvement by weeks — cavities can persist for months on imaging even after clinical cure. A residual thin-walled cyst after a lung abscess does not indicate treatment failure.

Secondary Lung Abscess

Secondary abscesses have worse outcomes because the underlying cause also needs treatment. Post-obstructive abscesses require treatment of the obstructing lesion (resection of lung cancer, retrieval of foreign body). Hematogenous abscesses require treatment of the source (endocarditis, septic thrombophlebitis) with prolonged intravenous antibiotics.

Major Complications

Mortality

Modern mortality rates for primary aspiration lung abscess are low (under 5%) with appropriate antibiotic therapy. Mortality is higher for secondary abscesses, particularly those due to S. aureus (especially post-influenza necrotizing pneumonia), immunocompromised hosts, and cases complicated by massive hemoptysis or empyema. Abscess in the context of underlying lung cancer carries the prognosis of the cancer rather than the abscess.

What Is Not Yet Known

A 2024 review found that high-quality evidence and guidelines for treating lung abscess are still lacking, and its authors called for prospective studies of drainage procedures and antibiotic regimens. The review lists structural lung disease, poor dental hygiene and ventilator-associated pneumonia as risk factors, notes that concern is now being raised about electronic cigarette use as a possible risk factor, and reports that early drainage through the chest wall could improve in-hospital outcomes.

Key Research Papers

  1. Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med. 1983;98(4):466-471. — PubMed PMID: 6838068
  2. Sperling S, Dahl VN, Fløe A. Lung abscess: an update on the current knowledge and call for future investigations. Curr Opin Pulm Med. 2024;30(3):229-234. — PubMed PMID: 38411181
  3. Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019;380(7):651-663. — PubMed PMID: 30763196
  4. Hammond JMJ, Lyddell C, Potgieter PD, Odell J. Severe pneumococcal pneumonia complicated by massive pulmonary gangrene. Chest. 1993;104(5):1610-1612. — PubMed PMID: 8222837
  5. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis. 2005;40(7):915-922. — PubMed PMID: 15824979
  6. Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y. Etiology and outcome of community-acquired lung abscess. Respiration. 2010;80(2):98-105. — PubMed PMID: 20389050
  7. Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess — etiology, diagnostic and treatment options. Ann Transl Med. 2015;3(13):183. — PubMed PMID: 26366400
  8. Moreira Jda S, Camargo Jde J, Felicetti JC, Goldenfun PR, Moreira AL, Porto Nda S. Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004. J Bras Pneumol. 2006;32(2):136-143. — PubMed PMID: 17273583
  9. Wali SO, Shugaeri A, Samman YS, Abdelaziz M. Percutaneous drainage of pyogenic lung abscess. Scand J Infect Dis. 2002;34(9):673-679. — PubMed PMID: 12374359
  10. Mori T, Ebe T, Takahashi M, Isonuma H, Ikemoto H, Oguri T. Lung abscess: analysis of 66 cases from 1979 to 1991. Intern Med. 1993;32(4):278-284. — PubMed PMID: 8358116
  11. Mansharamani NG, Koziel H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med. 2003;9(3):181-185. — PubMed PMID: 12682562
  12. Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis. 1979;119(1):19-23. — PubMed PMID: 420433
  13. Lee JH, Hong H, Tamburrini M, Park CM. Percutaneous transthoracic catheter drainage for lung abscess: a systematic review and meta-analysis. Eur Radiol. 2022;32(2):1184-1194. — PubMed PMID: 34327579

PubMed Topic Searches

The following PubMed topic searches retrieve current peer-reviewed literature on Lung Abscess. Each link opens a live PubMed query.

  1. PubMed: Lung abscess clindamycin anaerobic treatment
  2. PubMed: Aspiration pneumonia lung abscess
  3. PubMed: Klebsiella pneumoniae lung abscess
  4. PubMed: MRSA necrotizing pneumonia cavitation
  5. PubMed: Percutaneous drainage lung abscess
  6. PubMed: Lung abscess bronchoscopy drainage
  7. PubMed: Cavitary pneumonia differential diagnosis
  8. PubMed: Lung abscess empyema complication
  9. PubMed: Pulmonary abscess immunocompromised host
  10. PubMed: Oropharyngeal anaerobes aspiration infection

Back to Table of Contents

Connections

Back to Table of Contents